Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Estrada-Luna, Diego, Carreón-Torres, Elizabeth, González-Reyes, Susana, Martínez-Salazar, María Fernanda, Ortiz-Rodríguez, María Araceli, Ramírez-Moreno, Esther, Arias-Rico, José, Jiménez-Osorio, Angélica Saraí
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605437/
https://www.ncbi.nlm.nih.gov/pubmed/36295088
http://dx.doi.org/10.3390/life12101652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605437/
https://www.ncbi.nlm.nih.gov/pubmed/36295088
http://dx.doi.org/10.3390/life12101652

Ejemplares similares